Development of myasthenia gravis during interferon-alpha treatment for anti-HCV positive chronic hepatitis
- PMID: 8609521
- PMCID: PMC1073867
- DOI: 10.1136/jnnp.60.3.348-a
Development of myasthenia gravis during interferon-alpha treatment for anti-HCV positive chronic hepatitis
Similar articles
-
Exacerbation of myasthenia gravis during interferon-alpha treatment.J Neurol Sci. 1996 Dec;144(1-2):221-2. doi: 10.1016/s0022-510x(96)00235-3. J Neurol Sci. 1996. PMID: 8994129 No abstract available.
-
Myasthenia gravis in a patient with chronic active hepatitis C during interferon-alpha treatment.J Neurol Neurosurg Psychiatry. 1996 Mar;60(3):348. doi: 10.1136/jnnp.60.3.348. J Neurol Neurosurg Psychiatry. 1996. PMID: 8609520 Free PMC article. No abstract available.
-
Myasthenia gravis during interferon alfa therapy.Neurology. 1995 Feb;45(2):382-3. doi: 10.1212/wnl.45.2.382. Neurology. 1995. PMID: 7854543
-
[A case of myasthenia gravis which developed myasthenic crisis after alpha-interferon therapy for chronic hepatitis C].Rinsho Shinkeigaku. 1996 Aug;36(8):980-5. Rinsho Shinkeigaku. 1996. PMID: 8958752 Review. Japanese.
-
[A case of hyperthyroidism appeared during interferon treatment for chronic hepatitis C].Nihon Shokakibyo Gakkai Zasshi. 1993 Apr;90(4):818-22. Nihon Shokakibyo Gakkai Zasshi. 1993. PMID: 8492475 Review. Japanese. No abstract available.
Cited by
-
Side effects of interferon-alpha therapy.Pharm World Sci. 2005 Dec;27(6):423-31. doi: 10.1007/s11096-005-1319-7. Pharm World Sci. 2005. PMID: 16341948
-
Myasthenia Crisis Induced by Pegylated-Interferon in Patient With Chronic Hepatitis C: A Case Report.Medicine (Baltimore). 2016 May;95(21):e3782. doi: 10.1097/MD.0000000000003782. Medicine (Baltimore). 2016. PMID: 27227948 Free PMC article.
-
Cytokine-induced autoimmune disorders.Drug Saf. 1997 Aug;17(2):93-104. doi: 10.2165/00002018-199717020-00002. Drug Saf. 1997. PMID: 9285200 Review.
-
Myasthenia gravis: another autoimmune disease associated with hepatitis C virus infection.Dig Dis Sci. 1999 Jan;44(1):186-9. doi: 10.1023/a:1026683007277. Dig Dis Sci. 1999. PMID: 9952242
-
STAT1 deficiency unexpectedly and markedly exacerbates the pathophysiological actions of IFN-alpha in the central nervous system.Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16209-14. doi: 10.1073/pnas.252454799. Epub 2002 Dec 2. Proc Natl Acad Sci U S A. 2002. PMID: 12461178 Free PMC article.
References
-
- Ann N Y Acad Sci. 1976;274:116-29 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical